Glucocorticoid signaling and osteoarthritis.


Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 11 05 2018
revised: 03 10 2018
accepted: 11 11 2018
pubmed: 18 11 2018
medline: 18 5 2019
entrez: 17 11 2018
Statut: ppublish

Résumé

Glucocorticoids are steroid hormones synthesized and released by the adrenal cortex. Their main function is to maintain cell homeostasis through a variety of signaling pathways, responding to changes in an organism's environment or developmental status. Mimicking the actions of natural glucocorticoids, synthetic glucocorticoids have been recruited to treat many diseases that implicate glucocorticoid receptor signaling such as osteoarthritis. In osteoarthritis, synthetic glucocorticoids aim to alleviate inflammation and pain. The variation of patients' response and the possibility of complications associated with their long-term use have led to a need for a better understanding of glucocorticoid receptor signaling in osteoarthritis. In this review, we performed a literature search in the molecular pathways that link the osteoarthritic joint to the glucocorticoid receptor signaling. We hope that this information will advance research in the field and propose new molecular targets for the development of more optimized therapies for osteoarthritis.

Identifiants

pubmed: 30445185
pii: S0303-7207(18)30319-8
doi: 10.1016/j.mce.2018.11.001
pii:
doi:

Substances chimiques

Glucocorticoids 0
Receptors, Glucocorticoid 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-166

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Olga Savvidou (O)

First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University Hospital, Athens, Greece. Electronic address: olgasavvidou@gmail.com.

Mandy Milonaki (M)

Department of Clinical Biochemistry, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University Hospital, Athens, Greece. Electronic address: mandy.milonaki@gmail.com.

Stavros Goumenos (S)

First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University Hospital, Athens, Greece. Electronic address: stgoumenos@gmail.com.

Dimitrios Flevas (D)

First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University Hospital, Athens, Greece. Electronic address: dflevas@hotmail.com.

Panayiotis Papagelopoulos (P)

First Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University Hospital, Athens, Greece. Electronic address: pjporthopedic@gmail.com.

Paraskevi Moutsatsou (P)

Department of Clinical Biochemistry, National and Kapodistrian University of Athens, School of Medicine, "ATTIKON" University Hospital, Athens, Greece. Electronic address: pmoutsatsou@med.uoa.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH